Rockwell Medical (RMTI) Depreciation & Amortization (CF) (2016 - 2025)
Historic Depreciation & Amortization (CF) for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to $544000.0.
- Rockwell Medical's Depreciation & Amortization (CF) rose 18.42% to $544000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 9.14%. This contributed to the annual value of $2.2 million for FY2024, which is 5096.95% up from last year.
- Latest data reveals that Rockwell Medical reported Depreciation & Amortization (CF) of $544000.0 as of Q3 2025, which was up 18.42% from $563000.0 recorded in Q2 2025.
- In the past 5 years, Rockwell Medical's Depreciation & Amortization (CF) registered a high of $564000.0 during Q3 2023, and its lowest value of $133000.0 during Q4 2021.
- Over the past 5 years, Rockwell Medical's median Depreciation & Amortization (CF) value was $202000.0 (recorded in 2021), while the average stood at $342842.1.
- Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first plummeted by 3954.55% in 2021, then surged by 29440.56% in 2023.
- Over the past 5 years, Rockwell Medical's Depreciation & Amortization (CF) (Quarter) stood at $133000.0 in 2021, then grew by 15.79% to $154000.0 in 2022, then skyrocketed by 257.14% to $550000.0 in 2023, then decreased by 1.27% to $543000.0 in 2024, then grew by 0.18% to $544000.0 in 2025.
- Its Depreciation & Amortization (CF) was $544000.0 in Q3 2025, compared to $563000.0 in Q2 2025 and $539000.0 in Q1 2025.